DEFERIPRONE for Myelodysplastic syndrome: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 162 adverse event reports in the FDA FAERS database where DEFERIPRONE was used for Myelodysplastic syndrome.
Most Reported Side Effects for DEFERIPRONE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 916 | 36.8% | 91 | 304 |
| Death | 190 | 7.6% | 190 | 27 |
| Sickle cell anaemia with crisis | 167 | 6.7% | 1 | 156 |
| Nausea | 135 | 5.4% | 3 | 20 |
| Agranulocytosis | 126 | 5.1% | 8 | 68 |
| Vomiting | 111 | 4.5% | 3 | 24 |
| Ill-defined disorder | 106 | 4.3% | 9 | 100 |
| Fatigue | 99 | 4.0% | 1 | 22 |
| Neutropenia | 97 | 3.9% | 3 | 26 |
| Pyrexia | 87 | 3.5% | 7 | 53 |
| Abdominal discomfort | 83 | 3.3% | 1 | 11 |
| Prescribed overdose | 83 | 3.3% | 4 | 27 |
| Arthralgia | 76 | 3.1% | 4 | 23 |
| Diarrhoea | 76 | 3.1% | 2 | 26 |
| Haemoglobin decreased | 73 | 2.9% | 1 | 45 |
Other Indications for DEFERIPRONE
Haemochromatosis (1,537)
Transfusion (745)
Sickle cell disease (574)
Red blood cell transfusion (442)
Thalassaemia beta (389)
Thalassaemia (331)
Off label use (283)
Iron overload (164)
Sickle cell anaemia (125)
Iron metabolism disorder (78)
Other Drugs Used for Myelodysplastic syndrome
LENALIDOMIDE (14,132)
AZACITIDINE (5,741)
VENETOCLAX (2,508)
DEFERASIROX (1,445)
DARBEPOETIN ALFA (1,164)
RUXOLITINIB (886)
REVLIMID (835)
CEDAZURIDINE\DECITABINE (770)
LUSPATERCEPT-AAMT (609)
DECITABINE (429)